STANDING UP FOR YOU WITH SKILLED ADVOCACY

Bayer to settle US Essure contraceptive claims for $1.6 billion

Conceptus, Inc.’s product Essure was an implantable contraceptive device used by millions of women in the U.S. and abroad. Germany-based Bayer AG acquired Conceptus in 2013 for $1.1 billion. In 2016, the FDA required a safety warning on Essure’s label and Bayer stopped selling it in 2018. Unfortunately, thousands of women experienced adverse effects using

Skip to content